Philippines Health News API

{
    "totalArticles": 107816,
    "articles": [
        {
            "id": "8d6708471ccdb6ce3b13769db3a50386",
            "title": "Study supports routine childhood screening for type 1 diabetes",
            "description": "For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 diabetes in children can be detected in routine pediatric care.",
            "content": "For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 diabetes in children can be detected in routine pediatric care. The latest evaluation shows that the screening program is sustainab... [6432 chars]",
            "url": "https://www.news-medical.net/news/20260521/Study-supports-routine-childhood-screening-for-type-1-diabetes.aspx",
            "image": "https://www.news-medical.net/image-handler/picture/2014/7/Type_1_Diabetes-620x480.jpg",
            "publishedAt": "2026-05-22T03:43:00Z",
            "lang": "en",
            "source": {
                "id": "f2ca7a45d20357cb42858868cb4a4946",
                "name": "News-Medical",
                "url": "https://www.news-medical.net"
            }
        },
        {
            "id": "e5b6bf1d398c7cc95873f346c3d9b739",
            "title": "Nearly 1.2 billion people worldwide are living with mental disorders. The number has been growing",
            "description": "Nearly 1.2 billion people had a mental disorder in 2023, a new study has found — reflecting a 95.5% increase since 1990.",
            "content": "Nearly 1.2 billion people worldwide had mental disorders in 2023, reflecting a 95.5% increase since 1990, a new study has found.\nThe largest increases were in anxiety and depression, which were also the most common disorders in 2023. In third place w... [7141 chars]",
            "url": "https://www.yahoo.com/news/world/articles/nearly-1-2-billion-people-223054092.html",
            "image": "https://s.yimg.com/os/en/cnn_articles_875/547001e11e43cdfda9935f2a13f64053",
            "publishedAt": "2026-05-21T22:30:54Z",
            "lang": "en",
            "source": {
                "id": "99e8a2cb4638bb798cf9167e5af5b83b",
                "name": "Yahoo",
                "url": "https://www.yahoo.com"
            }
        },
        {
            "id": "4d050a5295b266f8cdaa2bee35174806",
            "title": "Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026",
            "description": "Not intended for US and UK media",
            "content": "Not intended for US and UK media\nNew patient-reported outcomes data shows improved function and reduced symptom burden with HERNEXEOS® (zongertinib tablets) as an initial treatment option in HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NS... [17536 chars]",
            "url": "https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/boehringer-ingelheims-oncology-portfolio-shows-strong-promise-across-multiple-cancers-at-asco-2026/2349700",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/22/1067764.png",
            "publishedAt": "2026-05-21T21:21:06Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}